Roflumilast foam 0.3%, a non-steroidal PDE4 inhibitor, has shown significant promise for treating psoriasis in adults and adolescents aged 12...

Researchers at the University of Copenhagen have developed a patch designed to make psoriasis treatment easier and more effective....

Patients with psoriasis have an increased risk of suicidal ideation and behavior (SIB) and depression. Bimekizumab, an interleukin (IL)-17A and...

Researchers of a recent study examined psoriasis in special body areas, such as the scalp, palmoplantar, genitals, and nails. The...

Psoriasis treatments for patients of all ages often include topicals, phototherapy, oral agents like methotrexate and cyclosporine, new oral inhibitors,...

Researchers of the LITE Study demonstrated that home-based phototherapy for psoriasis is non-inferior to office-based phototherapy across all skin types...